|
Mammalian Phenotype (MP): abnormal immune system cell morphology
(show info)
Phenotype Ontology
Like Gene Ontology (GO), phenotypy ontology classifies and organizes gene-mutant/null phenotypic information from the very general at the top to more specific terms in the directed acyclic graph (DAG) by viewing an individual term as a node and its relations to parental terms (allowing for multiple parents) as directed edges. To navigate this hierarchy, we display all parental phenotypic terms to the current phenotypic term of interest ordered by their shortest distances to the current term. Also, only direct children phenotypic terms of the current phenotypic term are listed. Phenotype ontologies we have incorporated are as follows:
- Disease Ontology (DO) Ontology (DO) DO semantically integrates disease and medical vocabularies through extensive cross mapping of DO terms to MeSH, ICD, NCI thesaurus, SNOMED and OMIM.
- Human Phenotype (HP) Ontology (HP) HP captures phenotypic abnormalities that are described in OMIM, along with the corresponding disease-causing genes. It includes three complementary biological concepts: Mode_of_Inheritance (MI), ONset_and_clinical_course (ON), and Phenotypic_Abnormality (PA).
- Mouse Phenotype (MP) Ontology (MP) MP describes phenotypes of the mouse after a specific gene is genetically disrupted. Using it, Mouse Genome Informatics (MGI) provides high-coverate gene-level phenotypes for the mouse.
- Worm Phenotype (WP) Ontology (WP) WP classifies and organizes phenotype descriptions for C. elegans and other nematodes. Using it, WormBase provides primary resource for phenotype annotations for C. elegans.
- Yeast Phenotype (YP) Ontology (YP) Based on YP which is the major contributor to the Ascomycete phenotype ontology, Saccharomyces Genome Database (SGD) provides single mutant phenotypes for every gene in the yeast genome.
- Fly Phenotype (FP) Ontology (FP) FP refers to FlyBase controlled vocabulary. Specifically, a structured controlled vocabulary is used for the annotation of alleles (for their mutagen etc) in FlyBase.
- Fly Anatomy (FA) Ontology (FA) FA is a structured controlled vocabulary of the anatomy of Drosophila melanogaster, used for the description of phenotypes and where a gene is expressed.
- Zebrafish Anatomy (ZA) Ontology (ZA) ZA displays anatomical terms of the zebrafish using standard anatomical nomenclature, together with affected genes.
- Xenopus Anatomy (XA) Ontology (XA) XA represents the lineage of tissues and the timing of development for frogs (Xenopus laevis and Xenopus tropicalis). It is used to annotate Xenopus gene expression patterns and mutant and morphant phenotypes.
- Arabidopsis Plant Ontology (AP) Ontology (AP) As a major contributor to Plant Ontology which describes plant anatomical and morphological structures (AN) and growth and developmental stages (DE), the Arabidopsis Information Resource (TAIR) provides arabidopsis plant ontology annotations for the model higher plant Arabidopsis thaliana.
- Enzyme Commission (EC) Ontology (EC) Each enzyme is allocated a four-digit EC number, the first three digits of which define the reaction catalysed and the fourth of which is a unique identifier (serial number). Each enzyme is also assigned a systematic name that uniquely defines the reaction catalysed.
- DrugBank ATC (DB) Ontology (DB) In the Anatomical Therapeutic Chemical (ATC) classification system, drugs are classified in groups at five different levels according to the organ or system (1st level, anatomical main group) on which they act and their therapeutic (2nd level, therapeutic subgroup), pharmacological (3rd level, pharmacological subgroup) and chemical properties (4th level, chemical subgroup; 5th level, chemical substance). Only drugs in DrugBank are considered.
- UniProtKB KeyWords (KW) Ontology (KW) Keywords in UniProtKB are controlled vocabulary, providing a summary of the entry content and are used to index UniProtKB/Swiss-Prot entries based on 10 categories (the category "Technical term" being excluded here). Each keyword is attributed manually to UniProtKB/Swiss-Prot entries and automatically to UniProtKB/TrEMBL entries (according to specific annotation rules).
- UniProtKB UniPathway (UP) Ontology (UP) UP is a fully manually curated resource for the representation and annotation of metabolic pathways, being used as controlled vocabulary for pathway annotation in UniProtKB.
Structural Domain Phenotype Ontology and its Annotations
Structural Classification of Proteins (SCOP) classifies evolutionary-related domains into Superfamily level and Family level. Using the phenotype ontologies above, we have generated the domain-centric phenotype annotations, and further identified those phenotype terms which are the most informative to annotate SCOP domains. Promisingly, domain-centric phenotypic annotations can serve as an alternative starting point to explore genotype-phenotype relationships. We provide several relevant files for the download, including the annotation and the corresponding ontology for each phenotype ontology.
- Structural Domain Disease Ontology (DO) Ontology (SDDO) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2DO.txt, and the corresponding ontology:SDDO.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Human Phenotype (HP) Ontology (SDHP) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2HP.txt, and the corresponding ontology:SDHP.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Mouse Phenotype (MP) Ontology (SDMP) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2MP.txt, and the corresponding ontology:SDMP.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Worm Phenotype (WP) Ontology (SDWP) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2WP.txt, and the corresponding ontology:SDWP.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Yeast Phenotype (YP) Ontology (SDYP) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2YP.txt, and the corresponding ontology:SDYP.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Fly Phenotype (FP) Ontology (SDFP) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2FP.txt, and the corresponding ontology:SDFP.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Fly Anatomy (FA) Ontology (SDFA) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2FA.txt, and the corresponding ontology:SDFA.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Zebrafish Anatomy (ZA) Ontology (SDZA) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2ZA.txt, and the corresponding ontology:SDZA.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Xenopus Anatomy (XA) Ontology (SDXA) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2XA.txt, and the corresponding ontology:SDXA.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Arabidopsis Plant Ontology (AP) Ontology (SDAP) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2AP.txt, and the corresponding ontology:SDAP.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Enzyme Commission (EC) Ontology (SDEC) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2EC.txt, and the corresponding ontology:SDEC.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain DrugBank ATC (DB) Ontology (SDDB) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2DB.txt, and the corresponding ontology:SDDB.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain UniProtKB KeyWords (KW) Ontology (SDKW) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2KW.txt, and the corresponding ontology:SDKW.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain UniProtKB UniPathway (UP) Ontology (SDUP) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2UP.txt, and the corresponding ontology:SDUP.txt) and mysql tables (Domain2PO.sql.gz).
Supra-domain Phenotype Ontology and its Annotations
Although domain-centric annotations hold great promise in describing phenotypic nature of independent domains, most domains themselves may not just work alone. In multi-domain proteins, they may be combined together to form distinct domain architectures. The recombination of the existing domains is considered as one of major driving forces for phenotypic diversificaation. As an extension, we have also generated supra-domain phenotype ontology and its annotations. Compared to domain-centric phenotype ontology and annotations (SCOP domains at the Superfamily level and Family level), this version focuses on supra-domains and individual SCOP domains ONLY at the Superfamily level. Besides, in terms of individual superfamilies, their annotations from the domain-centric version may be different from those from supra-domains version. Depending on your focus, the former should be used for the consideration of both the Superfamily level and Family level, otherwise the latter should be used if you are interested in domain combinations. Also, we provide several relevant files for the download, including the annotation and the corresponding ontology for each phenotype ontology.
- Supra-domain Domain Disease Ontology (DO) Ontology (SPDO) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2DO.txt, and the corresponding ontology:SPDO.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Human Phenotype (HP) Ontology (SPHO) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2HP.txt, and the corresponding ontology:SPHO.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Mouse Phenotype (MP) Ontology (SPMP) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2MP.txt, and the corresponding ontology:SPMP.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Worm Phenotype (WP) Ontology (SPWP) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2WP.txt, and the corresponding ontology:SPWP.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Yeast Phenotype (YP) Ontology (SPYP) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2YP.txt, and the corresponding ontology:SPYP.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Fly Phenotype (FP) Ontology (SPFP) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2FP.txt, and the corresponding ontology:SPFP.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Fly Anatomy (FA) Ontology (SPFA) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2FA.txt, and the corresponding ontology:SPFA.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Zebrafish Anatomy (ZA) Ontology (SPZA) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2ZA.txt, and the corresponding ontology:SPZA.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Xenopus Anatomy (XA) Ontology (SPXA) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2XA.txt, and the corresponding ontology:SPXA.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Arabidopsis Plant Ontology (AP) Ontology (SPAP) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2AP.txt, and the corresponding ontology:SPAP.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Enzyme Commission (EC) Ontology (SPEC) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2EC.txt, and the corresponding ontology:SPEC.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain DrugBank ATC (DB) Ontology (SPDB) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2DB.txt, and the corresponding ontology:SPDB.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain UniProtKB KeyWords (KW) Ontology (SPKW) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2KW.txt, and the corresponding ontology:SPKW.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain UniProtKB UniPathway (UP) Ontology (SPUP) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2UP.txt, and the corresponding ontology:SPUP.txt) and mysql tables (SP2PO.sql.gz).
Jump to [ Top · Phenotype Hierarchy · Superfamily · Family · Supra-domain ]
Root: MP Hierarchy (mammalian/mouse phenotype from MGI_4.41)
Jump to [ Top · Phenotype Hierarchy · Superfamily · Family · Supra-domain ]
Superfamily(show details)
Superfamily domains annotated to this MP term (Not in SDMP)
Highlighted in gray are those with FDR_all>0.001
Jump to [ Top · Phenotype Hierarchy · Superfamily · Family · Supra-domain ]
Family(show details)
Family domains annotated to this MP term (Not in SDMP)
Highlighted in gray are those with FDR_all>0.001
SCOP term | FDR (all) | Annotation (direct or inherited) |
Nitric oxide (NO) synthase oxygenase domain | 0 | DIRECT |
Proteasome subunits | 0 | DIRECT |
STAT DNA-binding domain | 0 | DIRECT |
RUNT domain | 0 | DIRECT |
DNA polymerase beta-like | 0 | DIRECT |
BAFF receptor-like | 0 | DIRECT |
Transcription factor STAT-4 N-domain | 0 | DIRECT |
C5 cytosine-specific DNA methylase, DCM | 0 | DIRECT |
STAT | 0 | DIRECT |
Interleukin 17F, IL-17F | 0 | DIRECT |
DNA polymerase beta-like, second domain | 0 | DIRECT |
TNF receptor-like | 0.00000006433 | DIRECT |
Interleukin 8-like chemokines | 0.00002032 | DIRECT |
Interleukin-1 (IL-1) | 0.004083 | INHERITED FROM: increased neutrophil cell number || increased granulocyte number || abnormal granulocyte morphology || abnormal neutrophil morphology || abnormal neutrophil cell number |
DNA polymerase beta, N-terminal domain-like | 0.004083 | INHERITED FROM: abnormal leukopoiesis || decreased leukocyte cell number || abnormal B cell differentiation || abnormal lymphocyte cell number || abnormal lymphopoiesis || abnormal B cell morphology || abnormal immunoglobulin V(D)J recombination || decreased lymphocyte cell number |
Interferons/interleukin-10 (IL-10) | 0.004591 | INHERITED FROM: abnormal phagocyte morphology |
Pointed domain | 0.004901 | INHERITED FROM: decreased leukocyte cell number || abnormal B cell differentiation || abnormal mature B cell morphology || abnormal lymphocyte cell number || decreased thymocyte number || decreased lymphocyte cell number |
Tissue inhibitor of metalloproteinases, TIMP | 0.01316 | INHERITED FROM: increased neutrophil cell number || increased granulocyte number || abnormal granulocyte number || abnormal granulocyte morphology || abnormal phagocyte morphology || abnormal neutrophil morphology || abnormal neutrophil cell number |
beta-glycanases | 0.01316 | INHERITED FROM: abnormal mononuclear phagocyte morphology || abnormal phagocyte morphology || abnormal macrophage morphology |
Triple coiled coil domain of C-type lectins | 0.01316 | INHERITED FROM: abnormal mononuclear phagocyte morphology || abnormal monocyte cell number || abnormal monocyte morphology || abnormal phagocyte morphology || abnormal macrophage morphology |
Cytochrome p450 reductase N-terminal domain-like | 0.01316 | INHERITED FROM: abnormal osteoclast morphology || abnormal mononuclear phagocyte morphology || increased osteoclast cell number || increased macrophage cell number || abnormal phagocyte morphology || abnormal macrophage morphology || abnormal macrophage cell number || abnormal osteoclast cell number |
E2F dimerization segment | 0.01405 | INHERITED FROM: abnormal leukopoiesis || abnormal T cell differentiation || abnormal T cell number || decreased double-positive T cell number || abnormal lymphopoiesis || abnormal alpha-beta T cell morphology |
Ran binding protein zinc finger-like | 0.01638 | INHERITED FROM: decreased B-1a cell number || decreased B cell number || abnormal B-1 B cell number || abnormal mature B cell morphology || abnormal B-1a B cell morphology || abnormal B cell morphology || abnormal B cell number |
V set domains (antibody variable domain-like) | 0.01783 | INHERITED FROM: abnormal T-helper 17 cell number || abnormal B-1 B cell number || abnormal T-helper 17 cell morphology |
Toll/Interleukin receptor TIR domain | 0.01892 | INHERITED FROM: abnormal B-1 B cell number || decreased mature B cell number || increased mature B cell number |
Interferon regulatory factor | 0.02405 | INHERITED FROM: abnormal mature B cell number || abnormal plasmacytoid dendritic cell number || decreased T cell number || abnormal plasmacytoid dendritic cell morphology || abnormal T cell number || decreased mature B cell number || decreased dendritic cell number || increased lymphocyte cell number || decreased plasmacytoid dendritic cell number |
C2 set domains | 0.02405 | INHERITED FROM: abnormal monocyte morphology |
Pleckstrin-homology domain (PH domain) | 0.02954 | INHERITED FROM: abnormal B-1 B cell number || decreased transitional stage B cell number |
SH2 domain | 0.03797 | INHERITED FROM: abnormal leukopoiesis || abnormal immature B cell number || abnormal B-1 B cell number || abnormal lymphopoiesis || decreased thymocyte number || abnormal pre-B cell morphology || decreased single-positive T cell number || arrested B cell differentiation || decreased immature B cell number || increased lymphocyte cell number |
NADPH-cytochrome p450 reductase-like | 0.03814 | INHERITED FROM: abnormal osteoclast morphology || increased osteoclast cell number || increased macrophage cell number || abnormal macrophage morphology || abnormal macrophage cell number || abnormal osteoclast cell number |
NADPH-cytochrome p450 reductase FAD-binding domain-like | 0.03814 | INHERITED FROM: abnormal osteoclast morphology || increased osteoclast cell number || increased macrophage cell number || abnormal macrophage morphology || abnormal macrophage cell number || abnormal osteoclast cell number |
Nuclear receptor coactivator interlocking domain | 0.03814 | INHERITED FROM: increased T cell number |
Tetraspanin | 0.03814 | INHERITED FROM: abnormal macrophage morphology |
SH3-domain | 0.04953 | INHERITED FROM: decreased single-positive T cell number || abnormal CD8-positive, alpha-beta T cell differentiation |
Myb/SANT domain | 0.06516 | INHERITED FROM: arrested B cell differentiation |
WWE domain | 0.07438 | INHERITED FROM: abnormal mature B cell number || abnormal marginal zone B cell morphology || decreased mature B cell number || decreased marginal zone B cell number |
Cell cycle transcription factor e2f-dp | 0.08651 | INHERITED FROM: abnormal T cell differentiation || decreased double-positive T cell number |
Interferon regulatory factor 3 (IRF3), transactivation domain | 0.1194 | INHERITED FROM: abnormal dendritic cell number || absent lymphocyte || abnormal plasmacytoid dendritic cell number || absent B cells || abnormal B cell differentiation || abnormal plasmacytoid dendritic cell morphology || decreased mature B cell number || abnormal dendritic cell morphology || decreased dendritic cell number || increased B cell number || decreased plasmacytoid dendritic cell number |
DEATH domain, DD | 0.131 | INHERITED FROM: abnormal B-1 B cell number || abnormal lymphocyte cell number || increased transitional stage B cell number || abnormal mononuclear cell morphology |
Integrin domains | 0.1501 | INHERITED FROM: decreased T cell number || decreased CD4-positive, alpha beta T cell number || abnormal eosinophil cell number |
ets domain | 0.1723 | INHERITED FROM: decreased pro-B cell number || decreased thymocyte number |
Short-chain cytokines | 0.2263 | INHERITED FROM: increased granulocyte number |
Higher-molecular-weight phosphotyrosine protein phosphatases | 0.2263 | INHERITED FROM: abnormal immature B cell number || abnormal B-2 B cell morphology || abnormal follicular B cell morphology || increased mature B cell number |
DBL homology domain (DH-domain) | 0.2358 | INHERITED FROM: abnormal transitional stage T2 B cell morphology || decreased transitional stage T2 B cell number || abnormal transitional stage T1 B cell morphology || increased transitional stage B cell number || decreased transitional stage B cell number || abnormal transitional stage B cell morphology || increased transitional stage T1 B cell number |
NF-kappa-B/REL/DORSAL transcription factors, C-terminal domain | 0.2591 | INHERITED FROM: abnormal leukopoiesis || abnormal dendritic cell number || abnormal T cell morphology || decreased leukocyte cell number || abnormal lymphocyte morphology || increased leukocyte cell number || decreased T cell number || decreased CD4-positive, alpha beta T cell number || abnormal B-1 B cell number || abnormal mature B cell morphology || abnormal leukocyte cell number || abnormal T cell number || abnormal lymphocyte cell number || abnormal phagocyte morphology || abnormal professional antigen presenting cell morphology || abnormal B cell morphology || abnormal macrophage cell number || abnormal dendritic cell morphology || decreased dendritic cell number || abnormal mononuclear cell morphology || abnormal osteoclast cell number || decreased CD8-positive, alpha-beta T cell number || abnormal B cell number || decreased lymphocyte cell number |
C1 set domains (antibody constant domain-like) | 0.2941 | INHERITED FROM: absent CD8-positive, alpha-beta T cells || abnormal leukocyte cell number || abnormal mononuclear cell morphology |
Rel/Dorsal transcription factors, DNA-binding domain | 0.2974 | INHERITED FROM: abnormal leukopoiesis || abnormal T cell morphology || decreased leukocyte cell number || abnormal lymphocyte morphology || increased leukocyte cell number || decreased T cell number || decreased CD4-positive, alpha beta T cell number || abnormal B-1 B cell number || abnormal mature B cell morphology || abnormal leukocyte cell number || abnormal T cell number || abnormal lymphocyte cell number || abnormal phagocyte morphology || abnormal professional antigen presenting cell morphology || abnormal B cell morphology || decreased dendritic cell number || abnormal mononuclear cell morphology || abnormal osteoclast cell number || abnormal leukocyte morphology || decreased CD8-positive, alpha-beta T cell number || abnormal B cell number || decreased lymphocyte cell number |
Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) | 0.3611 | INHERITED FROM: abnormal positive T cell selection || decreased thymocyte number |
Long-chain cytokines | 0.3902 | INHERITED FROM: abnormal osteoclast differentiation |
Pyrin domain, PYD | 0.3902 | INHERITED FROM: abnormal leukocyte cell number || abnormal granulocyte morphology || abnormal leukocyte morphology || abnormal neutrophil morphology || abnormal neutrophil cell number |
CCCH zinc finger | 0.4475 | INHERITED FROM: increased mature B cell number |
Bcl-2 inhibitors of programmed cell death | 0.4475 | INHERITED FROM: abnormal leukopoiesis || abnormal immature B cell number || abnormal mature B cell number || abnormal immature B cell morphology || increased pre-B cell number || abnormal T cell differentiation || abnormal T cell number || decreased mature B cell number || abnormal lymphopoiesis || abnormal pre-B cell morphology |
FHA domain | 0.4539 | INHERITED FROM: abnormal class switch recombination |
Calponin-homology domain, CH-domain | 0.4912 | INHERITED FROM: abnormal transitional stage T2 B cell morphology || decreased transitional stage T2 B cell number || abnormal transitional stage T1 B cell morphology || increased transitional stage B cell number || increased transitional stage T1 B cell number |
Caspase recruitment domain, CARD | 0.5125 | INHERITED FROM: abnormal follicular B cell morphology |
Phoshoinositide 3-kinase (PI3K) helical domain | 0.5125 | INHERITED FROM: abnormal CD8-positive, alpha-beta T cell number || abnormal effector T cell morphology || increased neutrophil cell number || increased granulocyte number || abnormal alpha-beta T cell number || abnormal CD4-positive, alpha beta T cell number || abnormal CD4-positive, alpha beta T cell morphology || abnormal CD8-positive, alpha beta T cell morphology || abnormal neutrophil cell number |
PLC-like (P variant) | 0.5743 | INHERITED FROM: abnormal leukopoiesis || decreased B-2 B cell number || abnormal B-1 B cell number |
MHC antigen-recognition domain | 0.6574 | INHERITED FROM: abnormal T cell morphology || absent CD8-positive, alpha-beta T cells || abnormal T cell number || abnormal mononuclear cell morphology |
Nuclear receptor ligand-binding domain | 0.6909 | INHERITED FROM: abnormal phagocyte morphology || abnormal macrophage cell number |
Nuclear receptor | 0.6909 | INHERITED FROM: abnormal phagocyte morphology || abnormal macrophage cell number |
Phoshoinositide 3-kinase (PI3K), catalytic domain | 0.7845 | INHERITED FROM: abnormal T cell morphology || decreased leukocyte cell number || abnormal CD8-positive, alpha-beta T cell number || abnormal lymphocyte morphology || abnormal T cell number || abnormal lymphocyte cell number || abnormal phagocyte morphology || abnormal CD4-positive, alpha beta T cell number || abnormal CD4-positive, alpha beta T cell morphology || abnormal CD8-positive, alpha beta T cell morphology || abnormal neutrophil cell number || decreased lymphocyte cell number |
MATH domain | 0.7986 | INHERITED FROM: abnormal immature B cell number || abnormal immature B cell morphology |
DNA polymerase I | 0.8555 | INHERITED FROM: abnormal B cell differentiation |
SCOP term | FDR (all) | Annotation (direct or inherited) |
Nitric oxide (NO) synthase oxygenase domain | 0 | Direct |
Proteasome subunits | 0 | Direct |
STAT DNA-binding domain | 0 | Direct |
RUNT domain | 0 | Direct |
DNA polymerase beta-like | 0 | Direct |
BAFF receptor-like | 0 | Direct |
Transcription factor STAT-4 N-domain | 0 | Direct |
C5 cytosine-specific DNA methylase, DCM | 0 | Direct |
STAT | 0 | Direct |
Interleukin 17F, IL-17F | 0 | Direct |
DNA polymerase beta-like, second domain | 0 | Direct |
TNF receptor-like | 0.00000006433 | Direct |
Interleukin 8-like chemokines | 0.00002032 | Direct |
Interleukin-1 (IL-1) | 0.004083 | Inherited |
DNA polymerase beta, N-terminal domain-like | 0.004083 | Inherited |
Interferons/interleukin-10 (IL-10) | 0.004591 | Inherited |
Pointed domain | 0.004901 | Inherited |
Tissue inhibitor of metalloproteinases, TIMP | 0.01316 | Inherited |
beta-glycanases | 0.01316 | Inherited |
Triple coiled coil domain of C-type lectins | 0.01316 | Inherited |
Cytochrome p450 reductase N-terminal domain-like | 0.01316 | Inherited |
E2F dimerization segment | 0.01405 | Inherited |
Ran binding protein zinc finger-like | 0.01638 | Inherited |
V set domains (antibody variable domain-like) | 0.01783 | Inherited |
Toll/Interleukin receptor TIR domain | 0.01892 | Inherited |
Interferon regulatory factor | 0.02405 | Inherited |
C2 set domains | 0.02405 | Inherited |
Pleckstrin-homology domain (PH domain) | 0.02954 | Inherited |
SH2 domain | 0.03797 | Inherited |
NADPH-cytochrome p450 reductase-like | 0.03814 | Inherited |
NADPH-cytochrome p450 reductase FAD-binding domain-like | 0.03814 | Inherited |
Nuclear receptor coactivator interlocking domain | 0.03814 | Inherited |
Tetraspanin | 0.03814 | Inherited |
SH3-domain | 0.04953 | Inherited |
Myb/SANT domain | 0.06516 | Inherited |
WWE domain | 0.07438 | Inherited |
Cell cycle transcription factor e2f-dp | 0.08651 | Inherited |
Interferon regulatory factor 3 (IRF3), transactivation domain | 0.1194 | Inherited |
DEATH domain, DD | 0.131 | Inherited |
Integrin domains | 0.1501 | Inherited |
ets domain | 0.1723 | Inherited |
Short-chain cytokines | 0.2263 | Inherited |
Higher-molecular-weight phosphotyrosine protein phosphatases | 0.2263 | Inherited |
DBL homology domain (DH-domain) | 0.2358 | Inherited |
NF-kappa-B/REL/DORSAL transcription factors, C-terminal domain | 0.2591 | Inherited |
C1 set domains (antibody constant domain-like) | 0.2941 | Inherited |
Rel/Dorsal transcription factors, DNA-binding domain | 0.2974 | Inherited |
Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) | 0.3611 | Inherited |
Long-chain cytokines | 0.3902 | Inherited |
Pyrin domain, PYD | 0.3902 | Inherited |
CCCH zinc finger | 0.4475 | Inherited |
Bcl-2 inhibitors of programmed cell death | 0.4475 | Inherited |
FHA domain | 0.4539 | Inherited |
Calponin-homology domain, CH-domain | 0.4912 | Inherited |
Caspase recruitment domain, CARD | 0.5125 | Inherited |
Phoshoinositide 3-kinase (PI3K) helical domain | 0.5125 | Inherited |
PLC-like (P variant) | 0.5743 | Inherited |
MHC antigen-recognition domain | 0.6574 | Inherited |
Nuclear receptor ligand-binding domain | 0.6909 | Inherited |
Nuclear receptor | 0.6909 | Inherited |
Phoshoinositide 3-kinase (PI3K), catalytic domain | 0.7845 | Inherited |
MATH domain | 0.7986 | Inherited |
DNA polymerase I | 0.8555 | Inherited |
Plot distribution on phylogenetic tree for Superfamily and/or Family domains annotated by this phenotype term
 |
Plot tree as:
| |
Download Newick format tree:
|
(show help)
Trees by TreeVector
A presence/absence matrix is generated using protein domain
architecture data for all genomes in SUPERFAMILY. The PAUP
software is used to produce a single, large tree topology using
heuristic parsimony methods. Genome combinations, or specific clades, can be displayed as
if individual trees had been produced. However, this data is extracted from the single
large tree. This produces a higher quality topology than if the trees had been produced
on their own, and allows the trees to be displayed instantly.
Jump to [ Top · Phenotype Hierarchy · Superfamily · Family · Supra-domain ]
Supra-domain (including individual superfamily)
(show details)
Supra-domains annotated to this MP term (Not in SPMP)
Highlighted in gray are those with FDR>0.001
(show details)
Supra-domains annotated to this MP term (Not in SPMP)
Highlighted in gray are those with FDR>0.001
Supra-domain (Duplex) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
48092,47655 48092 - Transcription factor STAT-4 N-domain 47655 - STAT | 0 | DIRECT |
47802,81585 47802 - DNA polymerase beta, N-terminal domain-like 81585 - PsbU/PolX domain-like | 0 | DIRECT |
81585,81301 81585 - PsbU/PolX domain-like 81301 - Nucleotidyltransferase | 0 | DIRECT |
49417,55550 49417 - p53-like transcription factors 55550 - SH2 domain | 0 | DIRECT |
47655,49417 47655 - STAT 49417 - p53-like transcription factors | 0 | DIRECT |
55550,55550 55550 - SH2 domain 55550 - SH2 domain | 0 | DIRECT |
47576,48065 47576 - Calponin-homology domain, CH-domain 48065 - DBL homology domain (DH-domain) | 0 | DIRECT |
50044,55550 50044 - SH3-domain 55550 - SH2 domain | 0.00000002451 | DIRECT |
55550,56112 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0.00000009135 | DIRECT |
57586,57586 57586 - TNF receptor-like 57586 - TNF receptor-like | 0.000000288 | DIRECT |
47986,47986 47986 - DEATH domain 47986 - DEATH domain | 0.001044 | INHERITED FROM: abnormal lymphocyte morphology || abnormal lymphocyte cell number || abnormal macrophage morphology || increased leukocyte cell number || abnormal mononuclear cell morphology || abnormal leukocyte morphology || abnormal myeloid leukocyte morphology || abnormal phagocyte morphology || abnormal leukocyte cell number || abnormal CD4-positive, alpha beta T cell number |
50729,55550 50729 - PH domain-like 55550 - SH2 domain | 0.001044 | INHERITED FROM: abnormal monocyte morphology || abnormal lymphocyte morphology || abnormal neutrophil morphology || abnormal neutrophil cell number || decreased B cell number || abnormal leukopoiesis || increased neutrophil cell number || increased lymphocyte cell number || abnormal mononuclear cell morphology || abnormal leukocyte morphology || abnormal B cell number || abnormal mature B cell morphology |
50729,56112 50729 - PH domain-like 56112 - Protein kinase-like (PK-like) | 0.001385 | INHERITED FROM: abnormal T cell differentiation || abnormal lymphocyte morphology || abnormal lymphocyte cell number || abnormal lymphopoiesis || abnormal alpha-beta T cell morphology || abnormal leukopoiesis || abnormal double-positive T cell morphology || abnormal T cell morphology || decreased lymphocyte cell number || abnormal mononuclear cell morphology || decreased T cell number || abnormal T cell number || decreased leukocyte cell number || abnormal leukocyte cell number |
49562,57889 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 57889 - Cysteine-rich domain | 0.01183 | INHERITED FROM: abnormal lymphopoiesis || abnormal leukopoiesis |
57944,56436 57944 - Triple coiled coil domain of C-type lectins 56436 - C-type lectin-like | 0.01183 | INHERITED FROM: abnormal monocyte morphology || abnormal macrophage morphology || abnormal monocyte cell number || abnormal phagocyte morphology || abnormal mononuclear phagocyte morphology |
46785,144074 46785 - "Winged helix" DNA-binding domain 144074 - E2F-DP heterodimerization region | 0.02812 | INHERITED FROM: abnormal T cell differentiation || abnormal lymphopoiesis || abnormal alpha-beta T cell morphology || abnormal leukopoiesis || decreased double-positive T cell number |
48726,48726 48726 - Immunoglobulin 48726 - Immunoglobulin | 0.02958 | INHERITED FROM: absent mast cells |
53300,69318 53300 - vWA-like 69318 - Integrin alpha N-terminal domain | 0.0506 | INHERITED FROM: decreased CD4-positive, alpha beta T cell number || increased CD8-positive, alpha-beta T cell number || increased alpha-beta T cell number |
57850,49599 57850 - RING/U-box 49599 - TRAF domain-like | 0.1601 | INHERITED FROM: abnormal immature B cell morphology || abnormal immature B cell number |
48065,50729 48065 - DBL homology domain (DH-domain) 50729 - PH domain-like | 0.1726 | INHERITED FROM: abnormal transitional stage B cell morphology || decreased transitional stage B cell number || increased transitional stage B cell number || abnormal transitional stage T1 B cell morphology || increased transitional stage T1 B cell number || abnormal transitional stage T2 B cell morphology || decreased transitional stage T2 B cell number |
49417,81296 49417 - p53-like transcription factors 81296 - E set domains | 0.2912 | INHERITED FROM: abnormal lymphocyte morphology || abnormal lymphocyte cell number || abnormal B-1 B cell number || abnormal leukopoiesis || abnormal B cell morphology || abnormal dendritic cell number || decreased dendritic cell number || decreased CD8-positive, alpha-beta T cell number || abnormal T cell morphology || decreased CD4-positive, alpha beta T cell number || decreased lymphocyte cell number || increased leukocyte cell number || abnormal mononuclear cell morphology || abnormal osteoclast cell number || abnormal leukocyte morphology || decreased T cell number || abnormal professional antigen presenting cell morphology || abnormal T cell number || decreased leukocyte cell number || abnormal B cell number || abnormal phagocyte morphology || abnormal mature B cell morphology || abnormal leukocyte cell number |
69318,69179 69318 - Integrin alpha N-terminal domain 69179 - Integrin domains | 0.2912 | INHERITED FROM: decreased T cell number |
69179,69179 69179 - Integrin domains 69179 - Integrin domains | 0.2912 | INHERITED FROM: decreased T cell number |
55550,50044 55550 - SH2 domain 50044 - SH3-domain | 0.3836 | INHERITED FROM: abnormal lymphocyte morphology || abnormal transitional stage B cell morphology || decreased mature B cell number || abnormal lymphocyte cell number || abnormal effector T cell morphology || abnormal alpha-beta T cell morphology || decreased single-positive T cell number || abnormal B-1 B cell number || decreased transitional stage B cell number || increased transitional stage B cell number || abnormal double-negative T cell morphology || increased lymphocyte cell number || increased immature B cell number || increased leukocyte cell number || arrested B cell differentiation || abnormal follicular B cell morphology || abnormal mature B cell number || decreased double-negative T cell number || abnormal transitional stage T2 B cell morphology || decreased immature B cell number || decreased follicular B cell number || abnormal immature B cell morphology || abnormal CD4-positive, alpha beta T cell number || abnormal immature B cell number |
54452,48726 54452 - MHC antigen-recognition domain 48726 - Immunoglobulin | 0.4321 | INHERITED FROM: abnormal T cell morphology || abnormal mononuclear cell morphology || absent CD8-positive, alpha-beta T cells || abnormal T cell number || abnormal leukocyte cell number |
49562,48371 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 48371 - ARM repeat | 0.5053 | INHERITED FROM: abnormal neutrophil morphology || abnormal neutrophil cell number || abnormal effector T cell morphology || abnormal alpha-beta T cell morphology || abnormal CD8-positive, alpha beta T cell morphology || increased neutrophil cell number || increased granulocyte number || abnormal CD4-positive, alpha beta T cell number || abnormal CD8-positive, alpha-beta T cell number || abnormal alpha-beta T cell number || abnormal CD4-positive, alpha beta T cell morphology |
57716,48508 57716 - Glucocorticoid receptor-like (DNA-binding domain) 48508 - Nuclear receptor ligand-binding domain | 0.6338 | INHERITED FROM: abnormal macrophage morphology || abnormal macrophage cell number || abnormal leukocyte morphology || abnormal myeloid leukocyte morphology || abnormal phagocyte morphology |
57667,57667 57667 - beta-beta-alpha zinc fingers 57667 - beta-beta-alpha zinc fingers | 0.6361 | INHERITED FROM: decreased DN2 thymocyte number |
48371,56112 48371 - ARM repeat 56112 - Protein kinase-like (PK-like) | 0.7929 | INHERITED FROM: abnormal CD8-positive, alpha beta T cell morphology || increased neutrophil cell number || abnormal CD4-positive, alpha beta T cell number || abnormal CD8-positive, alpha-beta T cell number || abnormal CD4-positive, alpha beta T cell morphology |
Supra-domain (Duplex) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
48092,47655 48092 - Transcription factor STAT-4 N-domain 47655 - STAT | 0 | Direct |
47802,81585 47802 - DNA polymerase beta, N-terminal domain-like 81585 - PsbU/PolX domain-like | 0 | Direct |
81585,81301 81585 - PsbU/PolX domain-like 81301 - Nucleotidyltransferase | 0 | Direct |
49417,55550 49417 - p53-like transcription factors 55550 - SH2 domain | 0 | Direct |
47655,49417 47655 - STAT 49417 - p53-like transcription factors | 0 | Direct |
55550,55550 55550 - SH2 domain 55550 - SH2 domain | 0 | Direct |
47576,48065 47576 - Calponin-homology domain, CH-domain 48065 - DBL homology domain (DH-domain) | 0 | Direct |
50044,55550 50044 - SH3-domain 55550 - SH2 domain | 0.00000002451 | Direct |
55550,56112 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0.00000009135 | Direct |
57586,57586 57586 - TNF receptor-like 57586 - TNF receptor-like | 0.000000288 | Direct |
47986,47986 47986 - DEATH domain 47986 - DEATH domain | 0.001044 | Inherited |
50729,55550 50729 - PH domain-like 55550 - SH2 domain | 0.001044 | Inherited |
50729,56112 50729 - PH domain-like 56112 - Protein kinase-like (PK-like) | 0.001385 | Inherited |
49562,57889 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 57889 - Cysteine-rich domain | 0.01183 | Inherited |
57944,56436 57944 - Triple coiled coil domain of C-type lectins 56436 - C-type lectin-like | 0.01183 | Inherited |
46785,144074 46785 - "Winged helix" DNA-binding domain 144074 - E2F-DP heterodimerization region | 0.02812 | Inherited |
48726,48726 48726 - Immunoglobulin 48726 - Immunoglobulin | 0.02958 | Inherited |
53300,69318 53300 - vWA-like 69318 - Integrin alpha N-terminal domain | 0.0506 | Inherited |
57850,49599 57850 - RING/U-box 49599 - TRAF domain-like | 0.1601 | Inherited |
48065,50729 48065 - DBL homology domain (DH-domain) 50729 - PH domain-like | 0.1726 | Inherited |
49417,81296 49417 - p53-like transcription factors 81296 - E set domains | 0.2912 | Inherited |
69318,69179 69318 - Integrin alpha N-terminal domain 69179 - Integrin domains | 0.2912 | Inherited |
69179,69179 69179 - Integrin domains 69179 - Integrin domains | 0.2912 | Inherited |
55550,50044 55550 - SH2 domain 50044 - SH3-domain | 0.3836 | Inherited |
54452,48726 54452 - MHC antigen-recognition domain 48726 - Immunoglobulin | 0.4321 | Inherited |
49562,48371 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 48371 - ARM repeat | 0.5053 | Inherited |
57716,48508 57716 - Glucocorticoid receptor-like (DNA-binding domain) 48508 - Nuclear receptor ligand-binding domain | 0.6338 | Inherited |
57667,57667 57667 - beta-beta-alpha zinc fingers 57667 - beta-beta-alpha zinc fingers | 0.6361 | Inherited |
48371,56112 48371 - ARM repeat 56112 - Protein kinase-like (PK-like) | 0.7929 | Inherited |
(show details)
Supra-domains annotated to this MP term (Not in SPMP)
Highlighted in gray are those with FDR>0.001
Supra-domain (Triple) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
50729,50044,55550 50729 - PH domain-like 50044 - SH3-domain 55550 - SH2 domain | 0 | DIRECT |
47802,81585,81301 47802 - DNA polymerase beta, N-terminal domain-like 81585 - PsbU/PolX domain-like 81301 - Nucleotidyltransferase | 0 | DIRECT |
48092,47655,49417 48092 - Transcription factor STAT-4 N-domain 47655 - STAT 49417 - p53-like transcription factors | 0 | DIRECT |
47655,49417,55550 47655 - STAT 49417 - p53-like transcription factors 55550 - SH2 domain | 0 | DIRECT |
55550,56112,56112 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) 56112 - Protein kinase-like (PK-like) | 0 | DIRECT |
50729,55550,56112 50729 - PH domain-like 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0 | DIRECT |
50044,55550,50044 50044 - SH3-domain 55550 - SH2 domain 50044 - SH3-domain | 0 | DIRECT |
47576,48065,50729 47576 - Calponin-homology domain, CH-domain 48065 - DBL homology domain (DH-domain) 50729 - PH domain-like | 0 | DIRECT |
50044,55550,56112 50044 - SH3-domain 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0.000003975 | DIRECT |
57196,57196,57184 57196 - EGF/Laminin 57196 - EGF/Laminin 57184 - Growth factor receptor domain | 0.002662 | INHERITED FROM: abnormal T cell morphology || decreased leukocyte cell number |
57586,57586,57586 57586 - TNF receptor-like 57586 - TNF receptor-like 57586 - TNF receptor-like | 0.003594 | INHERITED FROM: abnormal professional antigen presenting cell morphology |
49562,57889,57889 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 57889 - Cysteine-rich domain 57889 - Cysteine-rich domain | 0.01183 | INHERITED FROM: abnormal lymphopoiesis || abnormal leukopoiesis |
53300,69318,69179 53300 - vWA-like 69318 - Integrin alpha N-terminal domain 69179 - Integrin domains | 0.0506 | INHERITED FROM: decreased CD4-positive, alpha beta T cell number || increased CD8-positive, alpha-beta T cell number || increased alpha-beta T cell number |
69318,69179,69179 69318 - Integrin alpha N-terminal domain 69179 - Integrin domains 69179 - Integrin domains | 0.2912 | INHERITED FROM: decreased T cell number |
48726,48726,48726 48726 - Immunoglobulin 48726 - Immunoglobulin 48726 - Immunoglobulin | 0.3871 | INHERITED FROM: absent mast cells |
49562,48371,56112 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 48371 - ARM repeat 56112 - Protein kinase-like (PK-like) | 0.5053 | INHERITED FROM: abnormal neutrophil morphology || abnormal neutrophil cell number || abnormal effector T cell morphology || abnormal alpha-beta T cell morphology || abnormal CD8-positive, alpha beta T cell morphology || increased neutrophil cell number || increased granulocyte number || abnormal CD4-positive, alpha beta T cell number || abnormal CD8-positive, alpha-beta T cell number || abnormal alpha-beta T cell number || abnormal CD4-positive, alpha beta T cell morphology |
Supra-domain (Triple) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
50729,50044,55550 50729 - PH domain-like 50044 - SH3-domain 55550 - SH2 domain | 0 | Direct |
47802,81585,81301 47802 - DNA polymerase beta, N-terminal domain-like 81585 - PsbU/PolX domain-like 81301 - Nucleotidyltransferase | 0 | Direct |
48092,47655,49417 48092 - Transcription factor STAT-4 N-domain 47655 - STAT 49417 - p53-like transcription factors | 0 | Direct |
47655,49417,55550 47655 - STAT 49417 - p53-like transcription factors 55550 - SH2 domain | 0 | Direct |
55550,56112,56112 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) 56112 - Protein kinase-like (PK-like) | 0 | Direct |
50729,55550,56112 50729 - PH domain-like 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0 | Direct |
50044,55550,50044 50044 - SH3-domain 55550 - SH2 domain 50044 - SH3-domain | 0 | Direct |
47576,48065,50729 47576 - Calponin-homology domain, CH-domain 48065 - DBL homology domain (DH-domain) 50729 - PH domain-like | 0 | Direct |
50044,55550,56112 50044 - SH3-domain 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0.000003975 | Direct |
57196,57196,57184 57196 - EGF/Laminin 57196 - EGF/Laminin 57184 - Growth factor receptor domain | 0.002662 | Inherited |
57586,57586,57586 57586 - TNF receptor-like 57586 - TNF receptor-like 57586 - TNF receptor-like | 0.003594 | Inherited |
49562,57889,57889 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 57889 - Cysteine-rich domain 57889 - Cysteine-rich domain | 0.01183 | Inherited |
53300,69318,69179 53300 - vWA-like 69318 - Integrin alpha N-terminal domain 69179 - Integrin domains | 0.0506 | Inherited |
69318,69179,69179 69318 - Integrin alpha N-terminal domain 69179 - Integrin domains 69179 - Integrin domains | 0.2912 | Inherited |
48726,48726,48726 48726 - Immunoglobulin 48726 - Immunoglobulin 48726 - Immunoglobulin | 0.3871 | Inherited |
49562,48371,56112 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 48371 - ARM repeat 56112 - Protein kinase-like (PK-like) | 0.5053 | Inherited |
Plot distribution on phylogenetic tree for Supra-domains (Single/Individual) annotated by this phenotype term
 |
Plot tree as:
| |
Download Newick format tree:
|
(show help)
Trees by TreeVector
A presence/absence matrix is generated using protein domains and supradomains
for all genomes in SUPERFAMILY. The RAxML
software is used to produce a single, large tree topology using
heuristic parsimony methods. Genome combinations, or specific clades, can be displayed as
if individual trees had been produced. However, this data is extracted from the single
large tree. This produces a higher quality topology than if the trees had been produced
on their own, and allows the trees to be displayed instantly.
|